Palvella Therapeutics PVLA
NASDAQ PVLA
$129.41 -3.32 (-2.50%)
As of: Oct 2, 2026 · 3:47 PM EDT

Palvella Therapeutics (PVLA) Non-Current Deffered Revenue (2016 - 2023)

Updated

Palvella Therapeutics' Non-Current Deffered Revenue was $759,000 in Q2 2023, down 96.6% from $22.06 million a year earlier and down 93.5% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Non-Current Deffered Revenue (2016 - 2023) Analysis & Trends

At the end of FY2022, Non-Current Deffered Revenue at Palvella Therapeutics came in at $18.73 million, down 51.2% from FY2021.

  • Non-Current Deffered Revenue shows a five-year compound annual growth rate of -16.6% (FY2017 to FY2022).
  • In earlier years, Non-Current Deffered Revenue was $38.4 million in FY2021 (+7.0%), $35.9 million in FY2020 (-24.0%), $47.26 million in FY2019 (-11.3%) and $53.3 million in FY2018 (+14.5%).
  • The Q2 2023 figure marks the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2016.
  • Compared with a year earlier, Non-Current Deffered Revenue has declined for six straight quarters, with an average decline of 37.2% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q2 2021 (growth of 30.6%); the worst was Q2 2023 (a decline of 96.6%).
  • Per Business Quant data, PVLA's Non-Current Deffered Revenue in the three quarters before Q2 2023 was $11.73 million (Q1 2023), $18.73 million (Q4 2022) and $18.48 million (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Palvella Therapeutics 1.99 Bn 1.73 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 759,000.00
Mar 31, 2023 11.73 Mn
Dec 31, 2022 18.73 Mn
Sep 30, 2022 18.48 Mn
Jun 30, 2022 22.06 Mn
Mar 31, 2022 30.82 Mn
Dec 31, 2021 38.40 Mn
Sep 30, 2021 46.19 Mn
Jun 30, 2021 49.42 Mn
Mar 31, 2021 32.32 Mn
Dec 31, 2020 35.90 Mn
Sep 30, 2020 36.92 Mn
Jun 30, 2020 37.85 Mn
Mar 31, 2020 38.56 Mn
Dec 31, 2019 47.26 Mn
Sep 30, 2019 44.18 Mn
Jun 30, 2019 58.11 Mn
Mar 31, 2019 59.73 Mn
Dec 31, 2018 53.30 Mn
Sep 30, 2018 60.77 Mn
API Access

Palvella Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEY